|
thebestgene.com (Bestgene Inc) provides fast, cheap and high quality Drosophila transgenic (transgene/injection/microinjection/p-element transformation) service. (Drosophila, fly, fruit fly, P-element, embryo, Transgenic, microinjectoin, injection, transformation, transgene, service, facility, research, transgene service, Drosophila transgene, fly transgene, fruit fly transgene, Drosophila injection, fly injection, fruit fly injection, Drosophila microinjection, fly microinjection, fruit fly microinjection, p-element transformation service, Drosophila embryo microinjection, embryo microinjection, transposon injection, P-element injection, transgenic fruitfly, transgenic fly, transgenic Drosophila)
|
| |
PhiC31 integrase-mediated transgenesis systems
PhiC31 integrase-mediated transgenesis systems are based on the site-specific bacteriophage PhiC31 integrase which mediates sequence-directed, irreversible and highly efficient integration between a bacterial attachment site (attB) and a phage attachment site (attP). Injecting plasmid containing attB site and white marker into attP-containing docking site strain(s) with PhiC31 activity makes the resultant stable w+ transformants containing your gene-of-interest between attL and attR sites (irreversible).
P{CaryP}
Two attP landing sites were created by the Calos group. These two sites were initially created by the traditional P-element system. See below paper for more info.
PhiC31-mediated RMCE
In June, 2006, the Wu lab published a method that targets constructs to predetermined genomic sites using the phiC31 integrase system in conjunction with Recombinase Mediated Cassette Exchange (RMCE).
Please visit the Wu lab for more info:
http://genepath.med.harvard.edu/WuLab/RMCE
P[acman]
P[acman] system makes use of the combined tools of a conditional amplifiable technique for typical P1 and BAC construct, recombineering, and PhiC31-mediated trangenesis. It has the advantage of delivering large DNA fragments into specific genomic locations with attP site, which were generated by the Ballen lab and markered by yellow. Here we are incorporating the P[acman] system with the work from the Basler group which used endogenous PhiC31 source instead of co-injecting the PhiC31 mRNA.
Please visit the Bellen lab for more info:
http://flypush.imgen.bcm.tmc.edu/lab/index.html
MiMIC
MiMIC is a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes. MiMIC system was developed by the collaboration among the laboratories of Hugo Bellen (Baylor College of Medicine), Roger Hoskins (Lawrence Berkeley National Laboratory) and Allan Spradling (Carnegie Institution of Washington).
Please visit the Bellen lab MiMIC page for more info:
http://flypush.imgen.bcm.tmc.edu/pscreen/technique.html
FlyC31
In FlyC31 system, a library of landing platforms containing attP site throughout the Drosophila genome were created by the Basler group, which are ready for the transgenesis of the construct with attB site. These landing platforms were deliberately designed to be manipulated in vivo by Cre/loxP system after transgenesis to get rid of most of the non-necessary sequences and only keep your gene-of-interest flanking with one loxP and one attL site.
Please visit the FlyC31 website for more info:
http://www.frontiers-in-genetics.org/flyc31/
Perrimon Strains
Additional attP landing sites were created by the Perrimon group, and were tested for position effects by luciferase expression on various tissues. See below paper for more info.
Please visit the Perrimon lab website for more info:
http://genetics.med.harvard.edu/~perrimon/
The PhiC31 system and the Gateway System
One of the "Gateway-PhiC31 system", for example, can be found here. Please note the attP1, attP2, attB1, attB2, etc, at the original Murphys Gateway are of different concepts.
Reference:
Groth A, Fish M, Nusse R, Calos MP (2004) Construction of transgenic Drosophila by using the site-specific integrase from phage PhiC31. Genetics 166: 1775
Bateman JR, Lee AM, Wu C-t (2006) Site-specific transformation of Drosophila via PhiC31 integrase-mediated cassette exchange. Genetics 173:769
Venken KJT, He Y, Hoskins RA, Bellen HJ (2006) PhiC31: a BAC transgenic platform for targeted insertion of large DNA fragments in Drosophila melanogaster. Science 314:1747
Bischof J, Maeda RK, Hediger M, Karch F, Basler K (2007) An optimized transgenesis system for Drosophila using germ-line-specific PhiC31 integrases. PNAS 104:3312
Markstein M, Pitsouli C, Villalta C, Celniker SE, Perrimon N (2008) Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nature Genetics 40:476
Currently available Calos strains (P{CaryP} strains) at BestGene Inc.*
| Site name |
BDSC Stock# |
Genotype |
Estimated CytoSite# |
Transformant Eye Color1 |
Transformation Score [Avg. (BACs)]6 |
| attP1 |
8621 |
y1 w67c23; P{CaryP}attP1 |
55C4 |
Red |
3.1 (2.4) |
| attP2 |
8622 |
y1 w67c23; P{CaryP}attP2 |
68A4 |
Red |
4.8 (2.1) |
| attPY |
41124 |
y1 w*/Dp(2;Y)G; P{CaryP}attPY |
Y |
Red |
7.0 (nd) |
*We use the M{vas-int.Dm}ZH-2A as the stable genomic PhiC31 source, except for the X chromosome landing site strains. If you prefer to use the original landings site strains (without the genomic PhiC31 source) please contact us
#FlyBase Drosophila melanogaster (R5.47)
1Eye colors were determined three days after eclosion (heterozgous state)
6Transformation efficiency Score was calculated based on actual running orders and will be updated quarterly. Average score and >30kb BACs scores were shown
Currently available Wu strains and Bateman strains (PhiC31-RMCE strains) at BestGene Inc.*
| BDSC
Stock# |
Genotype |
Estimated CytoSite# |
Marker Expression Level |
Transformation Score6 |
| 27387 |
P{attP.w[+].attP}JB37B |
37B7 |
? |
8.5 |
| 27388 |
P{attP.w[+].attP}JB38F |
38F1 |
? |
5.6 |
| 27386 |
P{attP.w[+].attP}JB53F |
53F8 |
? |
2.6 |
| 25091 |
P{attP.w[+].attP}tara[JB89B] |
89B8 |
? |
- |
| 38451 |
w1118; Dr1/TM3, P{attP.w+.attP}FS10 Sb1 Ser1 |
79A2 |
? |
2.0 |
| 38452 |
w1118; Dr1/TM3, Sb1 Ser1 P{attP.w+.attP}FS18 |
100D1 |
? |
4.0 |
| 38453 |
y1 w*; snaSco/CyO, P{attP.w+.attP}J04 |
37B8 |
? |
4.0 |
| 38454 |
y1 w*; snaSco/CyO, P{attP.w+.attP}J08 |
37F2 |
? |
4.0 |
| 38455 |
FM7h, P{attP.w+.attP}FS2/C(1)DX, y1 f1 |
10B6 |
? |
4.0 |
| 38456 |
FM7h, P{attP.w+.attP}FS5/C(1)DX, y1 f1 |
6F3 |
? |
4.0 |
*We use the M{vas-int.Dm}ZH-2A as the stable genomic PhiC31 source, except for the X chromosome landing site strains. If you prefer to use the original landings site strains (without the genomic PhiC31 source) please contact us
#FlyBase Drosophila melanogaster (R5.47)
6Transformation efficiency Score was calculated based on actual running orders and will be updated quarterly
Currently available Bellen strains (P[acman] strains) at BestGene Inc.*
| BDSC
Stock# |
Genotype |
Estimated CytoSite# |
Transformant Eye Color1 |
Transformation Score [Avg. (BACs)]6 |
| 97292 |
PBac{yellow[+]-attP-3B}VK00010 |
chromosome 2 |
- |
- (nd) |
| 9734 |
PBac{yellow[+]-attP-9A}VK00015 |
chromosome 2 |
Red |
3.0 (2.4) |
| 9753 |
PBac{yellow[+]-attP-3B}VK00038 |
5B8 |
Red |
2.4 (2.4) |
| 9726 |
PBac{yellow[+]-attP-9A}VK00006 |
19E7 |
Light Orange |
1.8 (2.4) |
| 9752 |
PBac{yellow[+]-attP-3B}VK00037 |
22A3 |
Orange |
4.3 (2.9) |
| 9731 |
PBac{yellow[+]-attP-9A}VK00012 |
25A3 |
Light Orange |
0.0 (nd) |
| 9723 |
PBac{yellow[+]-attP-3B}VK00002
| 28E7 |
Red |
5.6 (3.1) |
| 9724 |
PBac{yellow[+]-attP-3B}VK00003ab |
31B1, 40A4 |
Red, Orange |
5.0 (3.0) |
| -12 |
PBac{yellow[+]-attP-3B}VK00003a |
31B1 |
Red? |
0.0 (nd) |
| -12 |
PBac{yellow[+]-attP-3B}VK00003b |
40A4 |
Orange? |
7.0 (nd) |
| 9730 |
PBac{yellow[+]-attP-3B}VK00011 |
40E4 |
Red |
0.3 (0.0) |
| 9733 |
PBac{yellow[+]-attP-9A}VK00014 |
43A1 |
Orange |
4.2 (3.6) |
| 9735 |
PBac{yellow[+]-attP-3B}VK00016 |
47C6 |
Orange |
2.0 (nd) |
| 9728 |
PBac{yellow[+]-attP-3B}VK00008 |
50A3 |
Light Orange |
- (nd) |
| 9747 |
PBac{yellow[+]-attP-9A}VK00030 |
50E1 |
Orange |
3.1 (2.2) |
| 9736 |
PBac{yellow[+]-attP-9A}VK00018 |
53B2 |
Red |
5.1 (1.9) |
| 9740 |
PBac{yellow[+]-attP-9A}VK00022 |
57F5 |
Orange |
4.5 (nd) |
| 9722 |
PBac{yellow[+]-attP-3B}VK00001 |
59D3 |
Orange |
4.1 (1.5) |
| 97462 |
PBac{yellow[+]-attP-9A}VK00029 |
h47-h53 |
- |
- (nd) |
| 9748 |
PBac{yellow[+]-attP-3B}VK00031 |
62E1 |
Orange |
5.3 (2.2) |
| 9750 |
PBac{yellow[+]-attP-3B}VK00033 |
65B2 |
Red |
4.7 (3.7) |
| 9754 |
PBac{yellow[+]-attP-3B}VK00039 |
67E4 |
- |
4.8 (nd) |
| 9737 |
PBac{yellow[+]-attP-9A}VK00019 |
68D2 |
Red |
4.2 (1.9) |
| 9741 |
PBac{yellow[+]-attP-9A}VK00023 |
70A2 |
Red |
4.0 (3.0) |
| 9751 |
PBac{yellow[+]-attP-3B}VK00036 |
70C4 |
Red |
- (nd) |
| 9725 |
PBac{yellow[+]-attP-9A}VK00005 |
75A10 |
Orange |
6.1 (1.8) |
| 9732 |
PBac{yellow[+]-attP-9A}VK00013 |
76A2 |
Red |
5.1 (3.3) |
| 9739 |
PBac{yellow[+]-attP-9A}VK00021 |
76C5 |
Orange |
- (nd) |
| 9727 |
PBac{yellow[+]-attP-3B}VK00007 |
82A1 |
Orange |
1.9 (nd) |
| 9749 |
PBac{yellow[+]-attP-3B}VK00032 |
85A2 |
Light Orange |
2.0 (0.0) |
| 9755 |
PBac{yellow[+]-attP-3B}VK00040 |
87B10 |
Red |
1.2 (nd) |
| 9744 |
PBac{yellow[+]-attP-9A}VK00027 |
89E11 |
Red |
5.9 (2.0) |
| 9745 |
PBac{yellow[+]-attP-9A}VK00028 |
92F1 |
Orange |
0.8 (2.4) |
| 9743 |
PBac{yellow[+]-attP-9A}VK00026 |
96F3 |
Light Orange |
3.2 (nd) |
| 9738 |
PBac{yellow[+]-attP-9A}VK00020 |
99F8 |
Light Orange |
5.4 (3.0) |
| 97422 |
PBac{yellow[+]-attP-9A}VK00024 |
101F1 |
- |
- (nd) |
*We use the M{vas-int.Dm}ZH-2A as the stable genomic PhiC31 source, except for the X chromosome landing site strains. If you prefer to use the original landings site strains (without the genomic PhiC31 source) please contact us
#FlyBase Drosophila melanogaster (R5.47)
1Eye colors were determined three days after eclosion (heterozgous state)
2These lines were very hard to transform
6Transformation efficiency Score was calculated based on actual running orders and will be updated quarterly. Average score and >30kb BACs scores were shown
12Donated by Jack Bateman 10/9/2009. Recombined single sites of 9724
Currently available Basler strains (FlyC31 strains) at BestGene Inc.
| BDSC Stock# |
Genotype |
Estimated CytoSite# |
Transformant Eye Color3 |
Transformation Score [Avg. (BACs)]6 |
| 24480 |
M{3xP3-RFP.attP'}ZH-2A
(with M{vas-int.Dm}ZH-102D) |
2A3 |
Orange |
2.6 (nd) |
| 24481 |
M{3xP3-RFP.attP'}ZH-22A
(with M{vas-int.Dm}ZH-2A) |
22A2 |
Light Orange |
4.9 (3.6) |
| 24482 |
M{3xP3-RFP.attP'}ZH-51C
(with M{vas-int.Dm}ZH-2A) |
51C1 |
Light Orange |
6.9 (2.6) |
| 244835 |
M{3xP3-RFP.attP}ZH-51D
(with M{vas-int.Dm}ZH-2A) |
51D9 |
Red |
5.9 (1.9) |
| 244844 |
M{3xP3-RFP.attP}ZH-58A
(with M{vas-int.Dm}ZH-2A) |
58A3 |
Light Orange |
7.2 (nd) |
| 24485 |
M{3xP3-RFP.attP'}ZH-68E
(with M{vas-int.Dm}ZH-2A) |
68E1 |
Light Orange |
7.1 (1.9) |
| 244864 |
M{3xP3-RFP.attP'}ZH-86Fa (with M{vas-int.Dm}ZH-2A) |
86E18 |
Red |
7.0 (2.0) |
236487 |
M{3xP3-RFP.attP}ZH-86Fb
(with M{vas-int.B}ZH-102D) |
86F8 |
Red |
7.6 (nd) |
| 24749 |
M{3xP3-RFP.attP}ZH-86Fb
(with M{vas-int.Dm}ZH-2A) |
86F8 |
Red |
7.1 (2.2) |
| 244874 |
M{3xP3-RFP.attP'}ZH-96E
(with M{vas-int.Dm}ZH-2A) |
96E10 |
Light Orange |
2.4 (nd) |
236478 |
M{3xP3-RFP.attP}ZH-102D
(with M{vas-int.B}ZH-86Fb) |
102D |
Red |
5.0 (nd) |
| 24488 |
M{3xP3-RFP.attP}ZH-102D
(with M{vas-int.Dm}ZH-2A) |
102F4 |
Red |
7.1 (nd) |
| - |
24480NF11 ZH-2A |
2A3 |
Orange |
2.0 (nd) |
| - |
24481NF11 ZH-22A |
22A2 |
Light Orange |
- (nd) |
| - |
24482NF11 ZH-51C |
51C1 |
Orange |
1.0 (nd) |
| - |
24483NF11 ZH-51D |
51D9 |
Red |
6.0 (nd) |
| - |
24484NF11 ZH-58A |
58A3 |
Light Orange |
2.0 (nd) |
| - |
24485NF11 ZH-68E |
68E1 |
Light Orange |
- (nd) |
| - |
24486NF11 ZH-86Fa |
86E18 |
Red |
4.0 (nd) |
| - |
24749NF11 ZH-86Fb |
86F8 |
Red |
5.0 (nd) |
|
|
|
#FlyBase Drosophila melanogaster (R5.47)
3According to FlyC31 website
4These strains are weak; BDSC#24486 is the weakest strain (low survival rate after injection)
5Enhancer trap effect from a nearby gene hibris and is not useful for reporter gene analysis and other applications where ectopic expression is an issue
6Transformation efficiency Score was calculated based on actual running orders and will be updated quarterly. Average score and >30kb BACs scores were shown
7Please use the 24749 if no special reason
8Please use the 24488 if no special reason
11M{vas-int.Dm}ZH-2A removed and loxP-3xP3-RFP-loxP removed version
Currently available Perrimon strains (P{CaryP} strains) at BestGene Inc.*
| Site name |
BDSC Stock# |
Genotype |
Estimated CytoSite# |
Transformant Eye Color1 |
Transformation Score [Avg. (BACs)]6 |
| attP18 |
32107 |
y1 w67c23 P{CaryP}attP18 |
6C12 |
Orange |
2.2 (nd) |
| attP4 |
- |
y1 w67c23 P{CaryP}attP4 |
12C6 |
Orange |
2.1 (nd) |
| attP3 |
32230 |
y1 w67c23 P{CaryP}attP3 |
19C4 |
Light Orange |
0.6 (0.9) |
| attP40 |
- |
y1 w67c23; P{CaryP}attP40 |
25C6 |
Red |
7.2 (4.6) |
| attP30 |
- |
y1 w67c23; P{CaryP}attP30 |
29C3-29C4 |
Red |
- (nd) |
| attP14 |
- |
y1 w67c23; P{CaryP}attP14 |
36A10 |
Orange |
1.7 (4.4) |
| attP33 |
- |
y1 w67c23; P{CaryP}attP33 |
50B6 |
Orange |
4.5 (0.9) |
| attP16 |
- |
y1 w67c23; P{CaryP}attP16 |
53C4 |
Red |
4.2 (2.4) |
| attP23 |
- |
y1 w67c23; P{CaryP}attP23 |
60C6-60C7 |
Red |
- (nd) |
| attP88 |
- |
y1 w67c23; P{CaryP}attP88 |
64A12 |
Red |
- (nd) |
| attP112 |
- |
y1 w67c23; P{CaryP}attP112 |
68C12-68C13 |
Red |
- (nd) |
| attP10 |
- |
y1 w67c23; P{CaryP}attP10 |
85D7/92B1 |
Orange |
0.7 (nd) |
| attP64 |
- |
y1 w67c23; P{CaryP}attP64 |
89B9 |
Red |
2.0 (nd) |
| attP52 |
- |
y1 w67c23; P{CaryP}attP52 |
89B9-89B12 |
? |
- (nd) |
| attP154 |
- |
y1 w67c23; P{CaryP}attP154 |
97D2 |
Orange |
4.3 (2.4) |
*We use the M{vas-int.Dm}ZH-2A as the stable genomic PhiC31 source, except for the X chromosome landing site strains. If you prefer to use the original landings site strains (without the genomic PhiC31 source) please contact us
#FlyBase Drosophila melanogaster (R5.47)
1Eye colors were determined three days after eclosion (heterozgous state)
6Transformation efficiency Score was calculated based on actual running orders and will be updated quarterly. Average score and >30kb BACs scores were shown
Other strains&
| Site name |
BDSC Stock# |
Genotype |
Estimated CytoSite# |
Transformant Eye Color1 |
Transformation Score [Avg. (BACs)]6 |
| su(Hw)attP8 |
32233 |
y1 w* P{CaryIP}su(Hw)attP8 |
8E10 |
Red |
3.5 (nd) |
| su(Hw)attP6 |
322329 |
y1 w* P{nos-phiC31\int.NLS}X; P{CaryIP}su(Hw)attP6 |
24A2 |
Red |
5.3 (nd) |
| su(Hw)attP6 |
347679 |
y1 w* P{CaryIP}su(Hw)attP6 |
24A2 |
Red |
5.0 (nd) |
| su(Hw)attP5 |
32231 |
y1 w* P{nos-phiC31\int.NLS}X; P{CaryIP}us(Hw)attP5 |
50F1 |
Red |
4.6 (nd) |
| su(Hw)attP5 |
34765 |
y1 w* P{CaryIP}su(Hw)attP5 |
50F1 |
Red |
2.1 (nd) |
| su(Hw)attP4 |
34763 |
y1 w* P{CaryIP}su(Hw)attP4 |
67E2 |
Red |
1.0 (nd) |
| su(Hw)attP2 |
347619 |
y1 w* P{CaryIP}su(Hw)attP2 |
92D9 |
Red |
3.5 (nd) |
| su(Hw)attP1 |
3476010 |
y1 w* P{CaryIP}su(Hw)attP1 |
87B13 |
Red |
6.0 (nd) |
| su(Hw)attP1 |
3556710 |
y1 w* P{nos-phiC31\int.NLS}X; P{CaryIP}su(Hw)attP1 |
87B13 |
Red |
4.8 (nd) |
&Some lines contain the nos-PhiC31 genomic integrase source as indicated at the genotype description. We use the M{vas-int.Dm}ZH-2A as the stable genomic PhiC31 source if the original site did not contain any PhiC31 genomic source, except for the X chromosome landing site strains. If you prefer to use the original landings site strains (without the genomic PhiC31 source) please contact us
#FlyBase Drosophila melanogaster (R5.47)
1Eye colors were determined three days after eclosion (heterozgous state)
6Transformation efficiency Score was calculated based on actual running orders and will be updated quarterly. Average score and >30kb BACs scores were shown
9This strain has very high non-specific integration rate. Service W (PCR confirmation of integration site) is highly recommended
10Service W is NOT available for this site
updated 5/14/2013
Highlighted are popular/preferred strains
|